“…CI is often observed in obese patients and in patients with type 2 diabetes, trisomy 21, rheumatoid arthritis, end-stage renal disease, kidney transplantation, or COVID-19 [ 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ]. In patients with hepatic failure, the altered chronotropic response correlates with the degree of organ failure, making it a valuable criterion in cardiovascular assessment when selecting candidates for liver transplantation [ 21 ]. In patients that have undergone Fontan surgery, chronotropic failure correlates with impaired exercise capacity, liver dysfunction, and platelet abnormalities; the heart rate reserve in these patients may be an indicator of organ complications, and it may serve as a precursor for development of bradyarrhythmia and the future need for treatment with an implantable cardiac electronic device [ 22 ].…”